Dasheng Wang

This publication record spans several distinct topics, including cancer drug combinations (such as sorafenib with kinase inhibitors in liver cancer), targeted protein degradation ('molecular glues'), plant-derived steroid compounds, biosensor development for disease marker detection, and pediatric epilepsy surgery outcomes. Because the underlying data mixes multiple apparently unrelated research areas and includes duplicate supplementary-data entries, it may reflect contributions from more than one individual or group sharing this name rather than a single coherent research program. Prospective students should verify the specific research focus and lab affiliation directly, as the bibliographic record alone does not clearly establish a unified research identity.

Publication counts were low or absent in several years of the past decade, then spiked sharply in 2023 with 17 outputs, suggesting an irregular rather than steadily growing pattern.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026